AMDL Acquires Combination Immunogene Therapy Technology for the Eradication of Human Tumors
...The GM-CSF gene enters the patient`s tumor and genetically alters the tumor so that it attracts the patient`s antigen presenting cells...... proved 100 percent effective in eradicating experimental human brain tumors implanted in mice,~~~ said Gary L. Dreher, AMDL president and CEO....
Oct 08 8:00 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/011008/82013_1.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines